Concepts (233)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteogenesis | 15 | 2015 | 69 | 2.230 |
Why?
|
| Transforming Growth Factor beta | 10 | 2014 | 37 | 1.950 |
Why?
|
| Femur | 16 | 2015 | 106 | 1.730 |
Why?
|
| Animals | 44 | 2021 | 1050 | 1.470 |
Why?
|
| Rats | 33 | 2021 | 234 | 1.380 |
Why?
|
| Bone Morphogenetic Protein 2 | 6 | 2014 | 21 | 1.240 |
Why?
|
| Rats, Sprague-Dawley | 28 | 2021 | 161 | 1.210 |
Why?
|
| Prostheses and Implants | 11 | 2020 | 59 | 1.170 |
Why?
|
| Ultrasonic Therapy | 4 | 2014 | 13 | 1.160 |
Why?
|
| Osteoporosis | 4 | 2020 | 25 | 1.080 |
Why?
|
| Bone Regeneration | 9 | 2015 | 58 | 1.050 |
Why?
|
| Bone Morphogenetic Proteins | 5 | 2015 | 23 | 0.890 |
Why?
|
| Osseointegration | 6 | 2021 | 41 | 0.880 |
Why?
|
| Bone Marrow Cells | 6 | 2010 | 29 | 0.750 |
Why?
|
| Male | 27 | 2020 | 1860 | 0.740 |
Why?
|
| Titanium | 10 | 2021 | 55 | 0.690 |
Why?
|
| Stromal Cells | 4 | 2010 | 16 | 0.680 |
Why?
|
| Implants, Experimental | 6 | 2021 | 25 | 0.650 |
Why?
|
| Prosthesis Failure | 5 | 2020 | 53 | 0.600 |
Why?
|
| Fracture Healing | 4 | 2017 | 13 | 0.600 |
Why?
|
| Disease Models, Animal | 7 | 2017 | 174 | 0.490 |
Why?
|
| Gene Expression Profiling | 5 | 2010 | 24 | 0.460 |
Why?
|
| Bone Marrow | 3 | 2015 | 21 | 0.460 |
Why?
|
| X-Ray Microtomography | 8 | 2021 | 63 | 0.440 |
Why?
|
| Prosthesis Implantation | 2 | 2012 | 9 | 0.430 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2014 | 16 | 0.430 |
Why?
|
| Recombinant Proteins | 8 | 2014 | 57 | 0.420 |
Why?
|
| Osteolysis | 4 | 2020 | 29 | 0.420 |
Why?
|
| Calcitonin | 1 | 2014 | 5 | 0.410 |
Why?
|
| Fracture Fixation | 1 | 2014 | 5 | 0.410 |
Why?
|
| Osteoporotic Fractures | 1 | 2014 | 5 | 0.410 |
Why?
|
| Bone Density Conservation Agents | 1 | 2014 | 6 | 0.410 |
Why?
|
| Diphosphonates | 1 | 2014 | 6 | 0.410 |
Why?
|
| Parathyroid Hormone | 1 | 2014 | 9 | 0.410 |
Why?
|
| Cell Differentiation | 3 | 2010 | 35 | 0.400 |
Why?
|
| Bone and Bones | 6 | 2017 | 69 | 0.400 |
Why?
|
| Receptors, CXCR4 | 2 | 2012 | 7 | 0.380 |
Why?
|
| Antibodies, Monoclonal | 1 | 2012 | 11 | 0.370 |
Why?
|
| Gene Expression Regulation | 3 | 2014 | 43 | 0.370 |
Why?
|
| Chemokine CXCL12 | 1 | 2012 | 2 | 0.360 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2014 | 85 | 0.360 |
Why?
|
| Osteoblasts | 5 | 2015 | 20 | 0.340 |
Why?
|
| Gap Junctions | 1 | 2011 | 3 | 0.330 |
Why?
|
| Cell Communication | 1 | 2011 | 7 | 0.330 |
Why?
|
| Cells, Cultured | 7 | 2011 | 119 | 0.320 |
Why?
|
| Bone Remodeling | 4 | 2019 | 38 | 0.320 |
Why?
|
| Antibodies | 3 | 2015 | 16 | 0.310 |
Why?
|
| Gene Expression | 3 | 2011 | 45 | 0.300 |
Why?
|
| Ultrasonics | 2 | 2005 | 7 | 0.280 |
Why?
|
| Osteocytes | 3 | 2014 | 14 | 0.270 |
Why?
|
| Bone Resorption | 5 | 2015 | 29 | 0.260 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2007 | 18 | 0.250 |
Why?
|
| Models, Animal | 10 | 2017 | 54 | 0.250 |
Why?
|
| Inflammation | 2 | 2020 | 31 | 0.230 |
Why?
|
| Biomarkers | 4 | 2019 | 101 | 0.230 |
Why?
|
| Anabolic Agents | 1 | 2004 | 3 | 0.220 |
Why?
|
| Graft Survival | 1 | 2004 | 10 | 0.220 |
Why?
|
| Humans | 9 | 2021 | 2957 | 0.210 |
Why?
|
| Genetic Markers | 2 | 2015 | 10 | 0.210 |
Why?
|
| Biomechanical Phenomena | 5 | 2020 | 95 | 0.200 |
Why?
|
| Signal Transduction | 3 | 2012 | 97 | 0.180 |
Why?
|
| Heterocyclic Compounds | 2 | 2012 | 5 | 0.180 |
Why?
|
| Ovariectomy | 3 | 2021 | 12 | 0.180 |
Why?
|
| Coated Materials, Biocompatible | 3 | 2007 | 12 | 0.170 |
Why?
|
| Bone Matrix | 2 | 2014 | 13 | 0.170 |
Why?
|
| Female | 6 | 2021 | 1724 | 0.170 |
Why?
|
| Osteocalcin | 2 | 2019 | 19 | 0.160 |
Why?
|
| Bone-Implant Interface | 1 | 2020 | 4 | 0.160 |
Why?
|
| Prosthesis Retention | 1 | 2020 | 4 | 0.160 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2020 | 15 | 0.160 |
Why?
|
| Joint Prosthesis | 1 | 2020 | 12 | 0.160 |
Why?
|
| Vitallium | 2 | 2011 | 8 | 0.160 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2011 | 30 | 0.160 |
Why?
|
| Prosthesis-Related Infections | 1 | 2020 | 26 | 0.160 |
Why?
|
| Body Weight | 1 | 2019 | 34 | 0.150 |
Why?
|
| Materials Testing | 5 | 2012 | 26 | 0.140 |
Why?
|
| Polyethylene | 2 | 2019 | 12 | 0.130 |
Why?
|
| Polymers | 2 | 2007 | 6 | 0.130 |
Why?
|
| Low-Level Light Therapy | 1 | 2017 | 1 | 0.130 |
Why?
|
| Calcium Phosphates | 3 | 2005 | 11 | 0.120 |
Why?
|
| Combined Modality Therapy | 2 | 2014 | 24 | 0.120 |
Why?
|
| Cobalt | 2 | 2014 | 9 | 0.120 |
Why?
|
| Up-Regulation | 2 | 2007 | 21 | 0.120 |
Why?
|
| Random Allocation | 2 | 2012 | 23 | 0.120 |
Why?
|
| Biomimetic Materials | 2 | 2006 | 5 | 0.120 |
Why?
|
| Benzylamines | 2 | 2012 | 11 | 0.110 |
Why?
|
| Nickel | 1 | 2014 | 6 | 0.110 |
Why?
|
| Wnt Proteins | 2 | 2012 | 9 | 0.110 |
Why?
|
| Glycoproteins | 1 | 2014 | 17 | 0.110 |
Why?
|
| Thiophenes | 1 | 2014 | 4 | 0.100 |
Why?
|
| Orthopedic Fixation Devices | 1 | 2014 | 5 | 0.100 |
Why?
|
| Time Factors | 4 | 2012 | 208 | 0.100 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2014 | 9 | 0.100 |
Why?
|
| Fractures, Bone | 1 | 2014 | 18 | 0.100 |
Why?
|
| Matrix Metalloproteinases | 2 | 2010 | 9 | 0.100 |
Why?
|
| Transforming Growth Factor beta2 | 4 | 2006 | 11 | 0.100 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2010 | 10 | 0.100 |
Why?
|
| Tensile Strength | 1 | 2012 | 4 | 0.090 |
Why?
|
| Drug Administration Schedule | 1 | 2012 | 14 | 0.090 |
Why?
|
| Reference Values | 1 | 2012 | 28 | 0.090 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2012 | 3 | 0.090 |
Why?
|
| Adult Stem Cells | 1 | 2012 | 3 | 0.090 |
Why?
|
| Cell Movement | 1 | 2012 | 12 | 0.090 |
Why?
|
| Risk Assessment | 1 | 2012 | 51 | 0.090 |
Why?
|
| Collagen | 1 | 2012 | 24 | 0.090 |
Why?
|
| Treatment Outcome | 1 | 2012 | 186 | 0.090 |
Why?
|
| Mice | 4 | 2015 | 343 | 0.090 |
Why?
|
| Electron Microscope Tomography | 1 | 2011 | 2 | 0.090 |
Why?
|
| Metals | 1 | 2011 | 9 | 0.090 |
Why?
|
| NFATC Transcription Factors | 1 | 2011 | 5 | 0.090 |
Why?
|
| Calcineurin | 1 | 2011 | 6 | 0.090 |
Why?
|
| Radiation Dosage | 1 | 2011 | 7 | 0.080 |
Why?
|
| Tissue Engineering | 2 | 2007 | 7 | 0.080 |
Why?
|
| Bayes Theorem | 1 | 2010 | 5 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2010 | 3 | 0.080 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 22 | 0.080 |
Why?
|
| Blotting, Western | 1 | 2010 | 23 | 0.080 |
Why?
|
| Transducers | 1 | 2010 | 5 | 0.080 |
Why?
|
| Alkaline Phosphatase | 1 | 2010 | 11 | 0.080 |
Why?
|
| Phosphorylation | 1 | 2010 | 28 | 0.080 |
Why?
|
| Equipment Design | 1 | 2010 | 21 | 0.080 |
Why?
|
| Matrix Metalloproteinase 13 | 2 | 2007 | 5 | 0.080 |
Why?
|
| Biocompatible Materials | 2 | 2007 | 16 | 0.080 |
Why?
|
| Femoral Fractures | 2 | 2006 | 9 | 0.080 |
Why?
|
| Sialoglycoproteins | 2 | 2007 | 6 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2005 | 18 | 0.070 |
Why?
|
| Down-Regulation | 2 | 2005 | 22 | 0.070 |
Why?
|
| Growth Substances | 2 | 2005 | 7 | 0.070 |
Why?
|
| Surface Properties | 3 | 2019 | 25 | 0.070 |
Why?
|
| Cell Line | 3 | 2014 | 56 | 0.070 |
Why?
|
| Acrylic Resins | 1 | 2007 | 2 | 0.060 |
Why?
|
| Dactinomycin | 1 | 2007 | 3 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2007 | 3 | 0.060 |
Why?
|
| Growth Differentiation Factor 5 | 1 | 2007 | 3 | 0.060 |
Why?
|
| Cycloheximide | 1 | 2007 | 4 | 0.060 |
Why?
|
| Guided Tissue Regeneration | 1 | 2006 | 3 | 0.060 |
Why?
|
| Extracellular Matrix | 1 | 2006 | 10 | 0.060 |
Why?
|
| Durapatite | 1 | 2005 | 5 | 0.060 |
Why?
|
| Sodium Chloride | 1 | 2005 | 8 | 0.060 |
Why?
|
| Osteonectin | 1 | 2005 | 4 | 0.060 |
Why?
|
| Genes, myc | 1 | 2005 | 4 | 0.060 |
Why?
|
| Genes, jun | 1 | 2005 | 4 | 0.060 |
Why?
|
| Immediate-Early Proteins | 1 | 2005 | 4 | 0.060 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2005 | 4 | 0.060 |
Why?
|
| Osteopontin | 1 | 2005 | 4 | 0.060 |
Why?
|
| Repressor Proteins | 1 | 2005 | 5 | 0.060 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2005 | 6 | 0.060 |
Why?
|
| Cyclooxygenase 2 | 1 | 2005 | 9 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2005 | 47 | 0.060 |
Why?
|
| Bone Marrow Purging | 1 | 2004 | 2 | 0.050 |
Why?
|
| Bone Transplantation | 1 | 2004 | 7 | 0.050 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2004 | 9 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 69 | 0.050 |
Why?
|
| Cell Culture Techniques | 1 | 2004 | 6 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 2 | 2014 | 21 | 0.050 |
Why?
|
| Regeneration | 2 | 2015 | 9 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2015 | 88 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2012 | 85 | 0.050 |
Why?
|
| Hip Prosthesis | 1 | 2002 | 60 | 0.040 |
Why?
|
| Bone Density | 2 | 2014 | 79 | 0.040 |
Why?
|
| Rats, Zucker | 1 | 2021 | 5 | 0.040 |
Why?
|
| Arthroplasty, Replacement | 1 | 2020 | 10 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2019 | 15 | 0.040 |
Why?
|
| Calcification, Physiologic | 1 | 2019 | 13 | 0.040 |
Why?
|
| Motor Activity | 1 | 2019 | 53 | 0.040 |
Why?
|
| Oligopeptides | 2 | 2007 | 8 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2007 | 24 | 0.030 |
Why?
|
| DNA Primers | 2 | 2005 | 12 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2015 | 5 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2005 | 59 | 0.030 |
Why?
|
| Mice, Inbred C3H | 1 | 2015 | 6 | 0.030 |
Why?
|
| Species Specificity | 1 | 2015 | 10 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2015 | 16 | 0.030 |
Why?
|
| Phenotype | 1 | 2015 | 75 | 0.030 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2014 | 4 | 0.030 |
Why?
|
| Molybdenum | 1 | 2014 | 4 | 0.030 |
Why?
|
| Chromium | 1 | 2014 | 5 | 0.030 |
Why?
|
| Cell Death | 1 | 2014 | 10 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 14 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2014 | 40 | 0.030 |
Why?
|
| Diaphyses | 1 | 2014 | 5 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2014 | 5 | 0.030 |
Why?
|
| Macaca fascicularis | 1 | 2014 | 5 | 0.030 |
Why?
|
| Humerus | 1 | 2014 | 14 | 0.030 |
Why?
|
| Tibia | 1 | 2014 | 33 | 0.030 |
Why?
|
| Lumbar Vertebrae | 1 | 2014 | 29 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 83 | 0.030 |
Why?
|
| Alloys | 2 | 2004 | 18 | 0.020 |
Why?
|
| Periosteum | 1 | 2012 | 4 | 0.020 |
Why?
|
| Radiography | 1 | 2012 | 53 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2012 | 3 | 0.020 |
Why?
|
| Colony-Forming Units Assay | 1 | 2012 | 4 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2012 | 23 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2012 | 25 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2012 | 12 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2012 | 47 | 0.020 |
Why?
|
| Calcineurin Inhibitors | 1 | 2011 | 4 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2011 | 9 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2011 | 22 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2011 | 47 | 0.020 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2011 | 52 | 0.020 |
Why?
|
| Rats, Long-Evans | 1 | 2009 | 4 | 0.020 |
Why?
|
| Ossification, Heterotopic | 1 | 2009 | 8 | 0.020 |
Why?
|
| Apoptosis | 1 | 2009 | 36 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2009 | 21 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2007 | 5 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2007 | 8 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2007 | 30 | 0.020 |
Why?
|
| Acrylates | 1 | 2007 | 2 | 0.020 |
Why?
|
| Ethylene Glycol | 1 | 2007 | 2 | 0.020 |
Why?
|
| Biomimetics | 1 | 2006 | 5 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2006 | 9 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2006 | 17 | 0.010 |
Why?
|
| Dogs | 1 | 2006 | 64 | 0.010 |
Why?
|
| Principal Component Analysis | 1 | 2005 | 2 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2005 | 10 | 0.010 |
Why?
|
| Hydroxyapatites | 1 | 2005 | 5 | 0.010 |
Why?
|
| Shear Strength | 1 | 2005 | 6 | 0.010 |
Why?
|
| Delayed-Action Preparations | 1 | 2005 | 9 | 0.010 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2005 | 7 | 0.010 |
Why?
|
| Base Sequence | 1 | 2005 | 24 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 19 | 0.010 |
Why?
|
| Temperature | 1 | 2004 | 11 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 2004 | 36 | 0.010 |
Why?
|
| Amino Acids | 1 | 2002 | 3 | 0.010 |
Why?
|
| Prosthesis Design | 1 | 2002 | 32 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2002 | 62 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2002 | 203 | 0.010 |
Why?
|
| Osteoarthritis | 1 | 2002 | 90 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2002 | 567 | 0.010 |
Why?
|
| Middle Aged | 1 | 2002 | 792 | 0.010 |
Why?
|
| Adult | 1 | 2002 | 794 | 0.010 |
Why?
|
| Aged | 1 | 2002 | 956 | 0.010 |
Why?
|